Global Pharmaceutical Plant Extracts Market

Pharmaceutical Plant Extracts Comprehensive Study by Type (Non-standardized Extracts, Standardized Extracts), Application (Ayurveda, Traditional Chinese Medicine, Western Herbalism, Homeopathy, Other), Solvents (Ethanol, Methanol, Acetone, Ethyl Acetate), Form (Capsule, Tablet, Powder, Soft Gel, Liquid) Players and Region - Global Market Outlook to 2028

Pharmaceutical Plant Extracts Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Pharmaceutical Plant Extracts Market?

Pharmaceutical plant extracts are obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. It involves the separation of medicinally active portions of plant tissues from inactive or inert components by using selective solvents in standard extraction procedures.

Highlights from Pharmaceutical Plant Extracts Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledIndena S.p.A. (Italy), Naturex (France), Ipsen (France), EUROMED S.A. (Spain), Sabinsa Corporation (United States), TSUMURA & CO. (Japan), Zhejiang CONBA Group Co., Ltd. (China), Shaanxi Jiahe Phytochem Co., Ltd. (China), Lingonberry Group (USA) Inc. (United States) and Guilin Layn Natural Ingredients Corp. (China)


The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Pharmaceutical Plant Extracts market throughout the forecasted period.

Indena S.p.A. (Italy), Naturex (France), Ipsen (France), EUROMED S.A. (Spain), Sabinsa Corporation (United States), TSUMURA & CO. (Japan), Zhejiang CONBA Group Co., Ltd. (China), Shaanxi Jiahe Phytochem Co., Ltd. (China), Lingonberry Group (USA) Inc. (United States) and Guilin Layn Natural Ingredients Corp. (China) are some of the key players profiled in the study.

Pharmaceutical Plant Extracts Market Segmentation:
ScopeSub-Segments
Application / End UserAyurveda, Traditional Chinese Medicine, Western Herbalism, Homeopathy and Other
TypeNon-standardized Extracts and Standardized Extracts
SolventsEthanol,Methanol,Acetone,Ethyl Acetate
FormCapsule,Tablet,Powder,Soft Gel,Liquid


On the basis of geography, the market of Pharmaceutical Plant Extracts has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advancement in the Extraction Process in Plant Extract

Market Growth Drivers:
High demand from pharmaceutical companies for new drug development and Increasing demand for plant-based medicines

Challenges:
Standardization and quality control challenges

Restraints:
Fluctuations in the raw material prices restraining the market

Opportunities:
Increasing demand for natural and plant-based medicines and Market expansion in emerging economies such as India, China, Brazil, and South Africa, offer significant growth potential for the pharmaceutical plant extracts market

Key Target Audience
Pharmaceutical Plant Extracts Manufacturers, Research Professionals, Emerging Companies, Distributors, Government Bodies & Associations and End-user

Market Leaders & Development Strategies
In April 2019, Ipsen and Clementia Pharmaceuticals announced the closing of Ipsen’s acquisition of Clementia following approval of the arrangement by Clementia shareholders and the Quebec Superior Court.
In October 2012, Indena launched its Enovita® Organic in collaboration with Alvinesa
The EMA is responsible for regulating human medicine regulations in the European Union. It evaluates and authorizes medicines for use throughout all of the European Union's member states, including plant extracts. The effectiveness, safety, and quality of pharmaceutical goods are evaluated scientifically by the EMA.

Report Objectives / Segmentation Covered

By Type
  • Non-standardized Extracts
  • Standardized Extracts
By Application
  • Ayurveda
  • Traditional Chinese Medicine
  • Western Herbalism
  • Homeopathy
  • Other
By Solvents
  • Ethanol
  • Methanol
  • Acetone
  • Ethyl Acetate

By Form
  • Capsule
  • Tablet
  • Powder
  • Soft Gel
  • Liquid

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High demand from pharmaceutical companies for new drug development
      • 3.2.2. Increasing demand for plant-based medicines
    • 3.3. Market Challenges
      • 3.3.1. Standardization and quality control challenges
    • 3.4. Market Trends
      • 3.4.1. Technological Advancement in the Extraction Process in Plant Extract
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Plant Extracts, by Type, Application, Solvents, Form and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Plant Extracts (Value)
      • 5.2.1. Global Pharmaceutical Plant Extracts by: Type (Value)
        • 5.2.1.1. Non-standardized Extracts
        • 5.2.1.2. Standardized Extracts
      • 5.2.2. Global Pharmaceutical Plant Extracts by: Application (Value)
        • 5.2.2.1. Ayurveda
        • 5.2.2.2. Traditional Chinese Medicine
        • 5.2.2.3. Western Herbalism
        • 5.2.2.4. Homeopathy
        • 5.2.2.5. Other
      • 5.2.3. Global Pharmaceutical Plant Extracts by: Solvents (Value)
        • 5.2.3.1. Ethanol
        • 5.2.3.2. Methanol
        • 5.2.3.3. Acetone
        • 5.2.3.4. Ethyl Acetate
      • 5.2.4. Global Pharmaceutical Plant Extracts by: Form (Value)
        • 5.2.4.1. Capsule
        • 5.2.4.2. Tablet
        • 5.2.4.3. Powder
        • 5.2.4.4. Soft Gel
        • 5.2.4.5. Liquid
      • 5.2.5. Global Pharmaceutical Plant Extracts Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Pharmaceutical Plant Extracts: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Indena S.p.A. (Italy)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Naturex (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ipsen (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. EUROMED S.A. (Spain)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sabinsa Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. TSUMURA & CO. (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Zhejiang CONBA Group Co., Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Shaanxi Jiahe Phytochem Co., Ltd. (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lingonberry Group (USA) Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Guilin Layn Natural Ingredients Corp. (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pharmaceutical Plant Extracts Sale, by Type, Application, Solvents, Form and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Plant Extracts (Value)
      • 7.2.1. Global Pharmaceutical Plant Extracts by: Type (Value)
        • 7.2.1.1. Non-standardized Extracts
        • 7.2.1.2. Standardized Extracts
      • 7.2.2. Global Pharmaceutical Plant Extracts by: Application (Value)
        • 7.2.2.1. Ayurveda
        • 7.2.2.2. Traditional Chinese Medicine
        • 7.2.2.3. Western Herbalism
        • 7.2.2.4. Homeopathy
        • 7.2.2.5. Other
      • 7.2.3. Global Pharmaceutical Plant Extracts by: Solvents (Value)
        • 7.2.3.1. Ethanol
        • 7.2.3.2. Methanol
        • 7.2.3.3. Acetone
        • 7.2.3.4. Ethyl Acetate
      • 7.2.4. Global Pharmaceutical Plant Extracts by: Form (Value)
        • 7.2.4.1. Capsule
        • 7.2.4.2. Tablet
        • 7.2.4.3. Powder
        • 7.2.4.4. Soft Gel
        • 7.2.4.5. Liquid
      • 7.2.5. Global Pharmaceutical Plant Extracts Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Plant Extracts: by Type(USD Million)
  • Table 2. Pharmaceutical Plant Extracts Non-standardized Extracts , by Region USD Million (2017-2022)
  • Table 3. Pharmaceutical Plant Extracts Standardized Extracts , by Region USD Million (2017-2022)
  • Table 4. Pharmaceutical Plant Extracts: by Application(USD Million)
  • Table 5. Pharmaceutical Plant Extracts Ayurveda , by Region USD Million (2017-2022)
  • Table 6. Pharmaceutical Plant Extracts Traditional Chinese Medicine , by Region USD Million (2017-2022)
  • Table 7. Pharmaceutical Plant Extracts Western Herbalism , by Region USD Million (2017-2022)
  • Table 8. Pharmaceutical Plant Extracts Homeopathy , by Region USD Million (2017-2022)
  • Table 9. Pharmaceutical Plant Extracts Other , by Region USD Million (2017-2022)
  • Table 10. Pharmaceutical Plant Extracts: by Solvents(USD Million)
  • Table 11. Pharmaceutical Plant Extracts Ethanol , by Region USD Million (2017-2022)
  • Table 12. Pharmaceutical Plant Extracts Methanol , by Region USD Million (2017-2022)
  • Table 13. Pharmaceutical Plant Extracts Acetone , by Region USD Million (2017-2022)
  • Table 14. Pharmaceutical Plant Extracts Ethyl Acetate , by Region USD Million (2017-2022)
  • Table 15. Pharmaceutical Plant Extracts: by Form(USD Million)
  • Table 16. Pharmaceutical Plant Extracts Capsule , by Region USD Million (2017-2022)
  • Table 17. Pharmaceutical Plant Extracts Tablet , by Region USD Million (2017-2022)
  • Table 18. Pharmaceutical Plant Extracts Powder , by Region USD Million (2017-2022)
  • Table 19. Pharmaceutical Plant Extracts Soft Gel , by Region USD Million (2017-2022)
  • Table 20. Pharmaceutical Plant Extracts Liquid , by Region USD Million (2017-2022)
  • Table 21. South America Pharmaceutical Plant Extracts, by Country USD Million (2017-2022)
  • Table 22. South America Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 23. South America Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 24. South America Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 25. South America Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 26. Brazil Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 27. Brazil Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 28. Brazil Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 29. Brazil Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 30. Argentina Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 31. Argentina Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 32. Argentina Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 33. Argentina Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 34. Rest of South America Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 35. Rest of South America Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 36. Rest of South America Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 37. Rest of South America Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 38. Asia Pacific Pharmaceutical Plant Extracts, by Country USD Million (2017-2022)
  • Table 39. Asia Pacific Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 40. Asia Pacific Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 41. Asia Pacific Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 42. Asia Pacific Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 43. China Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 44. China Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 45. China Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 46. China Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 47. Japan Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 48. Japan Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 49. Japan Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 50. Japan Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 51. India Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 52. India Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 53. India Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 54. India Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 55. South Korea Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 56. South Korea Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 57. South Korea Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 58. South Korea Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 59. Taiwan Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 60. Taiwan Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 61. Taiwan Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 62. Taiwan Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 63. Australia Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 64. Australia Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 65. Australia Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 66. Australia Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 71. Europe Pharmaceutical Plant Extracts, by Country USD Million (2017-2022)
  • Table 72. Europe Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 73. Europe Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 74. Europe Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 75. Europe Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 76. Germany Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 77. Germany Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 78. Germany Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 79. Germany Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 80. France Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 81. France Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 82. France Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 83. France Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 84. Italy Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 85. Italy Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 86. Italy Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 87. Italy Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 88. United Kingdom Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 89. United Kingdom Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 90. United Kingdom Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 91. United Kingdom Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 92. Netherlands Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 93. Netherlands Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 94. Netherlands Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 95. Netherlands Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 96. Rest of Europe Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 97. Rest of Europe Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 98. Rest of Europe Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 99. Rest of Europe Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 100. MEA Pharmaceutical Plant Extracts, by Country USD Million (2017-2022)
  • Table 101. MEA Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 102. MEA Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 103. MEA Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 104. MEA Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 105. Middle East Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 106. Middle East Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 107. Middle East Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 108. Middle East Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 109. Africa Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 110. Africa Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 111. Africa Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 112. Africa Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 113. North America Pharmaceutical Plant Extracts, by Country USD Million (2017-2022)
  • Table 114. North America Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 115. North America Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 116. North America Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 117. North America Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 118. United States Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 119. United States Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 120. United States Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 121. United States Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 122. Canada Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 123. Canada Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 124. Canada Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 125. Canada Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 126. Mexico Pharmaceutical Plant Extracts, by Type USD Million (2017-2022)
  • Table 127. Mexico Pharmaceutical Plant Extracts, by Application USD Million (2017-2022)
  • Table 128. Mexico Pharmaceutical Plant Extracts, by Solvents USD Million (2017-2022)
  • Table 129. Mexico Pharmaceutical Plant Extracts, by Form USD Million (2017-2022)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Pharmaceutical Plant Extracts: by Type(USD Million)
  • Table 141. Pharmaceutical Plant Extracts Non-standardized Extracts , by Region USD Million (2023-2028)
  • Table 142. Pharmaceutical Plant Extracts Standardized Extracts , by Region USD Million (2023-2028)
  • Table 143. Pharmaceutical Plant Extracts: by Application(USD Million)
  • Table 144. Pharmaceutical Plant Extracts Ayurveda , by Region USD Million (2023-2028)
  • Table 145. Pharmaceutical Plant Extracts Traditional Chinese Medicine , by Region USD Million (2023-2028)
  • Table 146. Pharmaceutical Plant Extracts Western Herbalism , by Region USD Million (2023-2028)
  • Table 147. Pharmaceutical Plant Extracts Homeopathy , by Region USD Million (2023-2028)
  • Table 148. Pharmaceutical Plant Extracts Other , by Region USD Million (2023-2028)
  • Table 149. Pharmaceutical Plant Extracts: by Solvents(USD Million)
  • Table 150. Pharmaceutical Plant Extracts Ethanol , by Region USD Million (2023-2028)
  • Table 151. Pharmaceutical Plant Extracts Methanol , by Region USD Million (2023-2028)
  • Table 152. Pharmaceutical Plant Extracts Acetone , by Region USD Million (2023-2028)
  • Table 153. Pharmaceutical Plant Extracts Ethyl Acetate , by Region USD Million (2023-2028)
  • Table 154. Pharmaceutical Plant Extracts: by Form(USD Million)
  • Table 155. Pharmaceutical Plant Extracts Capsule , by Region USD Million (2023-2028)
  • Table 156. Pharmaceutical Plant Extracts Tablet , by Region USD Million (2023-2028)
  • Table 157. Pharmaceutical Plant Extracts Powder , by Region USD Million (2023-2028)
  • Table 158. Pharmaceutical Plant Extracts Soft Gel , by Region USD Million (2023-2028)
  • Table 159. Pharmaceutical Plant Extracts Liquid , by Region USD Million (2023-2028)
  • Table 160. South America Pharmaceutical Plant Extracts, by Country USD Million (2023-2028)
  • Table 161. South America Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 162. South America Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 163. South America Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 164. South America Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 165. Brazil Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 166. Brazil Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 167. Brazil Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 168. Brazil Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 169. Argentina Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 170. Argentina Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 171. Argentina Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 172. Argentina Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 173. Rest of South America Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 174. Rest of South America Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 175. Rest of South America Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 176. Rest of South America Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 177. Asia Pacific Pharmaceutical Plant Extracts, by Country USD Million (2023-2028)
  • Table 178. Asia Pacific Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 179. Asia Pacific Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 180. Asia Pacific Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 181. Asia Pacific Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 182. China Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 183. China Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 184. China Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 185. China Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 186. Japan Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 187. Japan Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 188. Japan Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 189. Japan Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 190. India Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 191. India Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 192. India Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 193. India Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 194. South Korea Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 195. South Korea Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 196. South Korea Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 197. South Korea Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 198. Taiwan Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 199. Taiwan Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 200. Taiwan Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 201. Taiwan Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 202. Australia Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 203. Australia Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 204. Australia Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 205. Australia Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 206. Rest of Asia-Pacific Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 207. Rest of Asia-Pacific Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 208. Rest of Asia-Pacific Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 209. Rest of Asia-Pacific Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 210. Europe Pharmaceutical Plant Extracts, by Country USD Million (2023-2028)
  • Table 211. Europe Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 212. Europe Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 213. Europe Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 214. Europe Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 215. Germany Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 216. Germany Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 217. Germany Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 218. Germany Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 219. France Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 220. France Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 221. France Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 222. France Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 223. Italy Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 224. Italy Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 225. Italy Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 226. Italy Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 227. United Kingdom Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 228. United Kingdom Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 229. United Kingdom Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 230. United Kingdom Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 231. Netherlands Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 232. Netherlands Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 233. Netherlands Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 234. Netherlands Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 235. Rest of Europe Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 236. Rest of Europe Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 237. Rest of Europe Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 238. Rest of Europe Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 239. MEA Pharmaceutical Plant Extracts, by Country USD Million (2023-2028)
  • Table 240. MEA Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 241. MEA Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 242. MEA Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 243. MEA Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 244. Middle East Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 245. Middle East Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 246. Middle East Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 247. Middle East Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 248. Africa Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 249. Africa Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 250. Africa Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 251. Africa Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 252. North America Pharmaceutical Plant Extracts, by Country USD Million (2023-2028)
  • Table 253. North America Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 254. North America Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 255. North America Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 256. North America Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 257. United States Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 258. United States Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 259. United States Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 260. United States Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 261. Canada Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 262. Canada Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 263. Canada Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 264. Canada Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 265. Mexico Pharmaceutical Plant Extracts, by Type USD Million (2023-2028)
  • Table 266. Mexico Pharmaceutical Plant Extracts, by Application USD Million (2023-2028)
  • Table 267. Mexico Pharmaceutical Plant Extracts, by Solvents USD Million (2023-2028)
  • Table 268. Mexico Pharmaceutical Plant Extracts, by Form USD Million (2023-2028)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Plant Extracts: by Type USD Million (2017-2022)
  • Figure 5. Global Pharmaceutical Plant Extracts: by Application USD Million (2017-2022)
  • Figure 6. Global Pharmaceutical Plant Extracts: by Solvents USD Million (2017-2022)
  • Figure 7. Global Pharmaceutical Plant Extracts: by Form USD Million (2017-2022)
  • Figure 8. South America Pharmaceutical Plant Extracts Share (%), by Country
  • Figure 9. Asia Pacific Pharmaceutical Plant Extracts Share (%), by Country
  • Figure 10. Europe Pharmaceutical Plant Extracts Share (%), by Country
  • Figure 11. MEA Pharmaceutical Plant Extracts Share (%), by Country
  • Figure 12. North America Pharmaceutical Plant Extracts Share (%), by Country
  • Figure 13. Global Pharmaceutical Plant Extracts share by Players 2022 (%)
  • Figure 14. Global Pharmaceutical Plant Extracts share by Players (Top 3) 2022(%)
  • Figure 15. Global Pharmaceutical Plant Extracts share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Indena S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 18. Indena S.p.A. (Italy) Revenue: by Geography 2022
  • Figure 19. Naturex (France) Revenue, Net Income and Gross profit
  • Figure 20. Naturex (France) Revenue: by Geography 2022
  • Figure 21. Ipsen (France) Revenue, Net Income and Gross profit
  • Figure 22. Ipsen (France) Revenue: by Geography 2022
  • Figure 23. EUROMED S.A. (Spain) Revenue, Net Income and Gross profit
  • Figure 24. EUROMED S.A. (Spain) Revenue: by Geography 2022
  • Figure 25. Sabinsa Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Sabinsa Corporation (United States) Revenue: by Geography 2022
  • Figure 27. TSUMURA & CO. (Japan) Revenue, Net Income and Gross profit
  • Figure 28. TSUMURA & CO. (Japan) Revenue: by Geography 2022
  • Figure 29. Zhejiang CONBA Group Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 30. Zhejiang CONBA Group Co., Ltd. (China) Revenue: by Geography 2022
  • Figure 31. Shaanxi Jiahe Phytochem Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 32. Shaanxi Jiahe Phytochem Co., Ltd. (China) Revenue: by Geography 2022
  • Figure 33. Lingonberry Group (USA) Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Lingonberry Group (USA) Inc. (United States) Revenue: by Geography 2022
  • Figure 35. Guilin Layn Natural Ingredients Corp. (China) Revenue, Net Income and Gross profit
  • Figure 36. Guilin Layn Natural Ingredients Corp. (China) Revenue: by Geography 2022
  • Figure 37. Global Pharmaceutical Plant Extracts: by Type USD Million (2023-2028)
  • Figure 38. Global Pharmaceutical Plant Extracts: by Application USD Million (2023-2028)
  • Figure 39. Global Pharmaceutical Plant Extracts: by Solvents USD Million (2023-2028)
  • Figure 40. Global Pharmaceutical Plant Extracts: by Form USD Million (2023-2028)
  • Figure 41. South America Pharmaceutical Plant Extracts Share (%), by Country
  • Figure 42. Asia Pacific Pharmaceutical Plant Extracts Share (%), by Country
  • Figure 43. Europe Pharmaceutical Plant Extracts Share (%), by Country
  • Figure 44. MEA Pharmaceutical Plant Extracts Share (%), by Country
  • Figure 45. North America Pharmaceutical Plant Extracts Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Indena S.p.A. (Italy)
  • Naturex (France)
  • Ipsen (France)
  • EUROMED S.A. (Spain)
  • Sabinsa Corporation (United States)
  • TSUMURA & CO. (Japan)
  • Zhejiang CONBA Group Co., Ltd. (China)
  • Shaanxi Jiahe Phytochem Co., Ltd. (China)
  • Lingonberry Group (USA) Inc. (United States)
  • Guilin Layn Natural Ingredients Corp. (China)
Select User Access Type

Key Highlights of Report


Jun 2023 203 Pages 94 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharmaceutical Plant Extracts Market Quantitative research analysis
Global Pharmaceutical Plant Extracts Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"High demand from pharmaceutical companies for new drug development " is seen as one of major growth factors of Pharmaceutical Plant Extracts Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Pharmaceutical Plant Extracts market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Pharmaceutical Plant Extracts Market Report?

Have a Query? Click Here

Other Related Reports

Genomics Comprehensive Study by Application (Drug Discovery and Development, Diagnostics, Others), Services (NGS-based Services, Core Genomics Services, Biomarket Translation Services, Computational ...
$ 3650
Medicinal Fungi Comprehensive Study by Type (Micafungin, Mycophenolate, Rosuvastatin, Others), Application (Household, Commercial, Industrial), Form (Powder, Whole, Slices, Extract), End-use (Antioxi...
$ 3350
Chrysin Extract Comprehensive Study by Application (Food Additive, Cosmetics and Personal Care, Dietary Supplements, Pharmaceuticals, Others), Form (Liquid, Powder, Capsules), Distribution Channel (O...
$ 3450
Nano-drug Comprehensive Study by Type (Nanoparticles (Metal & Metal Oxide Nanoparticles, Liposomes, Polymers & polymer-drug conjugates, Hydrogel nanoparticles, Dendrimers, Inorganic nanoparticles), N...
$ 3750
Mice Model Comprehensive Study by Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Conditioned/Surgically Modified Mice), Application (Cancer Research, Inflammation...
$ 3750
Protein Purification & Isolation Comprehensive Study by End Users (Hospitals and Diagnostic Centers, Contract Research Organization, Academic Medical Institutes, Pharmaceuticals & Biotechnology), Pro...
$ 3800